UpHealth (UPHL) AI Stock Analysis

• Market Cap: $3.79K
• Dividend Yield: N/A
• Average Volume (3M): 149.63K
• Price to Earnings (P/E): ―
• Beta (1Y): -59.67
• Revenue Growth: -46.75%
• EPS Growth: 70.83%
• Country: US
• Employees: 374
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Equipment & Services
• EPS (TTM): -4.19
• Shares Outstanding: 18,932,192
• 10 Day Avg. Volume: 29,054
• 30 Day Avg. Volume: 149,633
• PEG Ratio: N/A
• Price to Book (P/B): 0.04
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.19
• Enterprise Value/Market Cap: 38.90K
• Enterprise Value/Revenue: 0.28
• Enterprise Value/Gross Profit: 3.52
• Enterprise Value/Ebitda: -0.61
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: ―

UpHealth's overall score reflects significant risks related to its financial performance, including profitability and liquidity challenges. While revenue growth is encouraging, the lack of technical analysis data and poor valuation metrics are concerning. The absence of clear earnings call guidance adds uncertainty to the company's outlook.

UpHealth Business Overview & Revenue Model

Company Description

UpHealth (UPHL) is a technology-driven healthcare company that operates across multiple sectors, including digital health, integrated care management, and telehealth services. The company's core products and services focus on enhancing patient care through innovative digital solutions and providing comprehensive healthcare delivery platforms for providers and patients.

How the Company Makes Money

UpHealth makes money through a diversified revenue model that includes subscription fees for its digital health platforms, service fees for telehealth consultations, and licensing fees for its integrated care management solutions. The company also partners with healthcare providers and organizations to offer customized services, contributing to its revenue streams. Key factors contributing to UpHealth's earnings include its ability to integrate with existing healthcare systems and the growing demand for telehealth and digital health services.

UpHealth Financial Statement Overview

Summary

UpHealth's financial performance is mixed. While the company has experienced revenue growth, it struggles with profitability and cash flow issues. Negative net income, high leverage, and liquidity challenges pose significant risks despite efforts to reduce liabilities.

Income Statement

UpHealth has shown significant revenue growth from 2019 to 2023, but profitability remains a challenge. The company has consistently reported negative net income, with a net loss of $57.84 million in 2023. Despite a positive gross profit margin of 48.55% in 2023, net profit margins are deeply negative, indicating high operational costs and inefficiencies.

Balance Sheet

The company's balance sheet reveals a high debt-to-equity ratio of 2.72, indicating significant leverage. Stockholders’ equity has decreased over the years, reflecting financial strain. However, the company has managed to reduce its total liabilities from the previous year, which is a positive sign. The equity ratio stands at 23.77%, suggesting a moderate reliance on debt financing.

Cash Flow

Cash flows are a concern, with negative operating and free cash flows reported in 2023. The operating cash flow to net income ratio is negative, highlighting the company's struggle to convert sales into cash. Free cash flow has improved slightly from 2022 to 2023, but remains negative, indicating ongoing liquidity challenges.

Breakdown	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	130.00M	158.80M	123.80M	5.40M	0.00
Gross Profit	69.59M	54.02M	30.54M	3.89M	0.00
EBITDA	-16.90M	-183.99M	-305.61M	-1.60M	-953.44K
Net Income	-57.84M	-223.00M	-341.02M	-2.19M	360.45K
Balance Sheet
Total Assets	231.81M	339.80M	569.31M	262.39M	175.77M
Cash, Cash Equivalents and Short-Term Investments	2.55M	15.56M	76.80M	2.37M	1.58M
Total Debt	150.05M	160.46M	121.50M	23.30M	0.00
Total Liabilities	176.70M	233.67M	235.46M	41.67M	339.96K
Stockholders Equity	55.10M	105.15M	318.46M	220.72M	175.43M
Cash Flow
Free Cash Flow	-21.64M	-29.28M	-66.54M	-1.14M	-1.48M
Operating Cash Flow	-17.67M	-22.44M	-62.82M	-1.14M	-1.48M
Investing Cash Flow	15.26M	-15.59M	743.00K	3.51M	-172.12M
Financing Cash Flow	-10.60M	-22.75M	135.87M	0.00	175.18M

UpHealth Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DOCS	73 Outperform	$11.72B	55.62	22.50%	―	19.98%	53.10%
TDOC	56 Neutral	$1.38B	―	-54.49%	―	-2.54%	-322.03%
AMWL	52 Neutral	$130.75M	―	-44.04%	―	2.79%	58.22%
Sector *	52 Neutral	$7.47B	-0.04	-63.86%	2.34%	16.17%	0.25%
CLOV	50 Neutral	$1.54B	―	-7.75%	―	-32.45%	80.24%
UPHL	45 Neutral	$3.79K	―	-104.96%	―	-46.75%	70.83%